Coherus BioSciences, Inc.
CHRS
$0.7818
-$0.0349-4.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.00% | -25.47% | 10.04% | 102.81% | -38.57% |
| Total Receivables | -53.04% | -8.18% | 121.90% | 180.06% | 136.92% |
| Inventory | 11.96% | -28.66% | -2.86% | 25.45% | 61.39% |
| Prepaid Expenses | -33.34% | -17.00% | -35.26% | -41.64% | -14.81% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -28.18% | -16.95% | 44.74% | 98.62% | 24.76% |
|
|
|||||
| Total Current Assets | -28.18% | -16.95% | 44.74% | 98.62% | 24.76% |
| Net Property, Plant & Equipment | -33.32% | -52.03% | -51.88% | -45.78% | -23.63% |
| Long-term Investments | -- | -- | -- | -- | 0.00% |
| Goodwill | -- | -- | -- | -- | 0.00% |
| Total Other Intangibles | -24.15% | 19.16% | 854.64% | 872.81% | 1,318.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -35.53% | -9.30% | -18.54% | 2.56% | -10.06% |
| Total Assets | -28.76% | -13.50% | 43.71% | 89.74% | 30.94% |
|
|
|||||
| Total Accounts Payable | -19.20% | -40.98% | 162.37% | 64.82% | 205.56% |
| Total Accrued Expenses | -22.01% | 16.99% | 76.35% | 205.44% | 136.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 32.35% | -14.77% | -7.38% | 3,885.82% | -50.32% |
| Total Finance Division Other Current Liabilities | 646.85% | 960.37% | -- | -- | -- |
| Total Other Current Liabilities | 646.85% | 960.37% | -- | -- | -- |
| Total Current Liabilities | -14.71% | 23.33% | 173.26% | 336.20% | 139.21% |
|
|
|||||
| Total Current Liabilities | -14.71% | 23.33% | 173.26% | 336.20% | 139.21% |
| Long-Term Debt | -38.20% | -38.25% | -38.57% | -36.46% | 0.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -38.33% | 160.24% | 58.85% | 22.96% | 5.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -86.20% | -50.64% | 1,600.00% | 2,580.39% | 262.30% |
| Total Liabilities | -29.47% | -17.34% | 17.79% | 41.15% | 33.12% |
|
|
|||||
| Common Stock & APIC | 2.38% | 3.37% | 9.33% | 14.24% | 15.10% |
| Retained Earnings | 1.80% | -0.03% | -2.01% | -4.18% | -17.73% |
| Treasury Stock & Other | -10.89% | -3.77% | 8.42% | 2.16% | 0.40% |
| Total Common Equity | 31.76% | 34.15% | 51.87% | 58.35% | -40.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.76% | 34.15% | 51.87% | 58.35% | -40.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.76% | 34.15% | 51.87% | 58.35% | -40.76% |
|
|
|||||
